309 related articles for article (PubMed ID: 21746769)
1. Non-Edg family LPA receptors: the cutting edge of LPA research.
Yanagida K; Ishii S
J Biochem; 2011 Sep; 150(3):223-32. PubMed ID: 21746769
[TBL] [Abstract][Full Text] [Related]
2. Structural insights into ligand recognition by the lysophosphatidic acid receptor LPA
Taniguchi R; Inoue A; Sayama M; Uwamizu A; Yamashita K; Hirata K; Yoshida M; Tanaka Y; Kato HE; Nakada-Nakura Y; Otani Y; Nishizawa T; Doi T; Ohwada T; Ishitani R; Aoki J; Nureki O
Nature; 2017 Aug; 548(7667):356-360. PubMed ID: 28792932
[TBL] [Abstract][Full Text] [Related]
3. Current progress in non-Edg family LPA receptor research.
Yanagida K; Kurikawa Y; Shimizu T; Ishii S
Biochim Biophys Acta; 2013 Jan; 1831(1):33-41. PubMed ID: 22902318
[TBL] [Abstract][Full Text] [Related]
4. Identification of p2y9/GPR23 as a novel G protein-coupled receptor for lysophosphatidic acid, structurally distant from the Edg family.
Noguchi K; Ishii S; Shimizu T
J Biol Chem; 2003 Jul; 278(28):25600-6. PubMed ID: 12724320
[TBL] [Abstract][Full Text] [Related]
5. Lysophosphatidic acid (LPA) signaling via LPA
Takahashi K; Fukushima K; Onishi Y; Inui K; Node Y; Fukushima N; Honoki K; Tsujiuchi T
Biochem Biophys Res Commun; 2017 Jan; 483(1):652-657. PubMed ID: 27993681
[TBL] [Abstract][Full Text] [Related]
6. Role of LPA4/p2y9/GPR23 in negative regulation of cell motility.
Lee Z; Cheng CT; Zhang H; Subler MA; Wu J; Mukherjee A; Windle JJ; Chen CK; Fang X
Mol Biol Cell; 2008 Dec; 19(12):5435-45. PubMed ID: 18843048
[TBL] [Abstract][Full Text] [Related]
7. The role of lysophosphatidic acid in the physiology and pathology of the skin.
Lei L; Su J; Chen J; Chen W; Chen X; Peng C
Life Sci; 2019 Mar; 220():194-200. PubMed ID: 30584899
[TBL] [Abstract][Full Text] [Related]
8. Cell density-dependent expression of EDG family receptors and mesangial cell proliferation: role in lysophosphatidic acid-mediated cell growth.
Xing Y; Ganji SH; Noh JW; Kamanna VS
Am J Physiol Renal Physiol; 2004 Dec; 287(6):F1250-7. PubMed ID: 15292052
[TBL] [Abstract][Full Text] [Related]
9. Lysophosphatidic acid-induced YAP/TAZ activation promotes developmental angiogenesis by repressing Notch ligand Dll4.
Yasuda D; Kobayashi D; Akahoshi N; Ohto-Nakanishi T; Yoshioka K; Takuwa Y; Mizuno S; Takahashi S; Ishii S
J Clin Invest; 2019 Jul; 129(10):4332-4349. PubMed ID: 31335323
[TBL] [Abstract][Full Text] [Related]
10. Ki16425, a subtype-selective antagonist for EDG-family lysophosphatidic acid receptors.
Ohta H; Sato K; Murata N; Damirin A; Malchinkhuu E; Kon J; Kimura T; Tobo M; Yamazaki Y; Watanabe T; Yagi M; Sato M; Suzuki R; Murooka H; Sakai T; Nishitoba T; Im DS; Nochi H; Tamoto K; Tomura H; Okajima F
Mol Pharmacol; 2003 Oct; 64(4):994-1005. PubMed ID: 14500756
[TBL] [Abstract][Full Text] [Related]
11. Diverse effects of LPA4, LPA5 and LPA6 on the activation of tumor progression in pancreatic cancer cells.
Ishii S; Hirane M; Fukushima K; Tomimatsu A; Fukushima N; Tsujiuchi T
Biochem Biophys Res Commun; 2015 May; 461(1):59-64. PubMed ID: 25849892
[TBL] [Abstract][Full Text] [Related]
12. Lysophosphatidic acid (LPA) and endothelial differentiation gene (Edg) receptors in human pancreatic cancer.
Lv GM; Li P; Wang WD; Wang ShK; Chen JF; Gong YL
J Surg Oncol; 2011 Nov; 104(6):685-91. PubMed ID: 21744351
[TBL] [Abstract][Full Text] [Related]
13. LPA induces osteoblast differentiation through interplay of two receptors: LPA1 and LPA4.
Liu YB; Kharode Y; Bodine PV; Yaworsky PJ; Robinson JA; Billiard J
J Cell Biochem; 2010 Mar; 109(4):794-800. PubMed ID: 20069565
[TBL] [Abstract][Full Text] [Related]
14. Non-Edg family lysophosphatidic acid (LPA) receptors.
Ishii S; Noguchi K; Yanagida K
Prostaglandins Other Lipid Mediat; 2009 Sep; 89(3-4):57-65. PubMed ID: 19524700
[TBL] [Abstract][Full Text] [Related]
15. Comparative analyses of lysophosphatidic acid receptor-mediated signaling.
Fukushima N; Ishii S; Tsujiuchi T; Kagawa N; Katoh K
Cell Mol Life Sci; 2015 Jun; 72(12):2377-94. PubMed ID: 25732591
[TBL] [Abstract][Full Text] [Related]
16. Comparing the differential effects of LPA on the barrier function of human pulmonary endothelial cells.
Ren Y; Guo L; Tang X; Apparsundaram S; Kitson C; Deguzman J; Fuentes ME; Coyle L; Majmudar R; Allard J; Truitt T; Hamid R; Chen Y; Qian Y; Budd DC
Microvasc Res; 2013 Jan; 85():59-67. PubMed ID: 23084965
[TBL] [Abstract][Full Text] [Related]
17. Differential expressions and DNA methylation patterns of lysophosphatidic acid receptor genes in human colon cancer cells.
Tsujino M; Fujii M; Okabe K; Mori T; Fukushima N; Tsujiuchi T
Virchows Arch; 2010 Dec; 457(6):669-76. PubMed ID: 20890765
[TBL] [Abstract][Full Text] [Related]
18. Differential targeting of lysophosphatidic acid LPA
Olianas MC; Dedoni S; Onali P
Eur J Pharmacol; 2023 Nov; 959():176064. PubMed ID: 37758013
[TBL] [Abstract][Full Text] [Related]
19. Cell surface receptors in lysophospholipid signaling.
Anliker B; Chun J
Semin Cell Dev Biol; 2004 Oct; 15(5):457-65. PubMed ID: 15271291
[TBL] [Abstract][Full Text] [Related]
20. The LPA receptors.
Fukushima N; Chun J
Prostaglandins Other Lipid Mediat; 2001 Apr; 64(1-4):21-32. PubMed ID: 11324705
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]